Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Other Non Operating Income (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Other Non Operating Income came in at -$331.0 million in Q2 2026, down 209.35% year-over-year from $302.7 million in Q2 2025, and down 12.59% quarter-over-quarter from -$294.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Other Non Operating Income (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$331.0 million for Q2 2026.

  • In Q2 2026, Other Non Operating Income fell 209.35% year-over-year to -$331.0 million; the TTM figure through Jun 2026 stood at -$630.0 million (down 111.3% YoY), while the FY2025 annual figure was $7.2 billion, up 253.58% from the prior year.
  • Other Non Operating Income came in at -$331.0 million for Q2 2026 at Johnson & Johnson, down from -$294.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $7.3 billion in Q1 2025 to a low of -$6.9 billion in Q2 2023.
  • Average Other Non Operating Income over 5 years is -$303.9 million, with a median of -$283.5 million recorded in 2022.
  • Year-over-year, Other Non Operating Income plunged 6903.92% in 2023 and soared 404.53% in 2025.
  • Over 5 years, Other Non Operating Income stood at -$226.0 million in 2022, then surged by 286.28% to $421.0 million in 2023, then slumped by 61.76% to $161.0 million in 2024, then slumped by 400.0% to -$483.0 million in 2025, then soared by 31.47% to -$331.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$331.0 million in Q2 2026, -$294.0 million in Q1 2026, and -$483.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -331.00 Mn
Mar 29, 2026 -294.00 Mn
Dec 28, 2025 -483.00 Mn
Sep 28, 2025 478.00 Mn
Jun 29, 2025 -107.00 Mn
Mar 30, 2025 7.32 Bn
Dec 29, 2024 161.00 Mn
Sep 29, 2024 -1.80 Bn
Jun 30, 2024 -653.00 Mn
Mar 31, 2024 -2.40 Bn
Dec 31, 2023 421.00 Mn
Oct 1, 2023 -499.00 Mn
Jul 2, 2023 384.00 Mn
Apr 2, 2023 -6.94 Bn
Jan 1, 2023 -330.00 Mn
Oct 2, 2022 -226.00 Mn
Jul 3, 2022 -273.00 Mn
Apr 3, 2022 102.00 Mn
Oct 3, 2021 -1.85 Bn
Jul 4, 2021 488.00 Mn